Volume 20 - Issue 10 - October, 2008
Feature
Original Contribution
10/08/2008
ABSTRACT: MGuard is a bare-metal stent covered by an ultra-thin polymer mesh sleeve on its external surface, designed to reduce embolization during coronary, cerebrovascular and peripheral interventions. Aim. To evaluate the feasibility and...
ABSTRACT: MGuard is a bare-metal stent covered by an ultra-thin polymer mesh sleeve on its external surface, designed to reduce embolization during coronary, cerebrovascular and peripheral interventions. Aim. To evaluate the feasibility and...
ABSTRACT: MGuard is a bare-metal...
10/08/2008
Journal of Invasive Cardiology
Original Contribution
10/08/2008
ABSTRACT: Background. We report the late outcomes in 411 consecutive patients undergoing drug-eluting stent (DES) implantation by a single operator between 2003–2006. Methods. Prospective registry with continuous follow up. Patients with...
ABSTRACT: Background. We report the late outcomes in 411 consecutive patients undergoing drug-eluting stent (DES) implantation by a single operator between 2003–2006. Methods. Prospective registry with continuous follow up. Patients with...
ABSTRACT: Background. We report...
10/08/2008
Journal of Invasive Cardiology
Insights
Commentary
10/08/2008
Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much...
Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much...
Since the approval of the...
10/08/2008
Journal of Invasive Cardiology